Precore wild-type DNA and immune complexes persist in chronic hepatitis B after seroconversion: No association between genome conversion and seroconversion

Hepatology

Volumn 27, Issue 1, 1998, Pages 245-253

  Maruyama, T ^a   Kuwata, S ^a   Koike, K ^a   Iino, S ^a   Yasuda, K ^a   Yotsuyanagi, H ^a   Moriya, K ^a   Maekawa, H ^a   Yamada, H ^a   Shibata, Y ^a   Milich, D R ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN ANTIBODY COMPLEX; ARTICLE; CHRONIC HEPATITIS; CLINICAL ARTICLE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; PRIORITY JOURNAL; SEROCONVERSION; VIRUS GENE;

EID: 0031961851     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510270137     Document Type: Article

References (32)

1. 1 Beasley RP, Hwang L‐Y, Lin C‐C, Chien C‐S. Hepatocellular carcinoma and hepatitis B virus. Lancet 1981 ; II: 1129–1133.
2. 2 Ou J‐H, Laub O, Rutter WJ. Hepatitis B virus gene function: the precore region targets the core antigen to cellular membranes and causes the secretion of the e antigen. Proc Natl Acad Sci U S A 1986 ; 83: 1578–1582. MEDLINE
3. 3 Bruss V, Gerlich WH. Formation of transmembraneous hepatitis B e‐antigen by cotranslational in vitro processing of the viral precore protein. Virology 1988 ; 163: 268–275. MEDLINE
4. 4 Milich DR, McLachlan A. The nucleocapsid of hepatitis B virus is both a T‐cell–independent and a T‐cell–dependent antigen. Science 1986 ; 234: 1398–1401. MEDLINE
5. 5 Milich DR, McLachlan A, Moriarty A, Thornton GB. Immune response to hepatitis B virus core antigen (HBcAg): localization of T cell recognition sites within HBcAg/HBeAg. J Immunol 1987 ; 139: 1223–1231. MEDLINE
6. 6 Ferrari C, Penna A, Sansoni P, Giuberti T, Neri TM, Chisari FV, Fiaccadori F. Selective sensitization of peripheral blood T lymphocytes to hepatitis B core antigen in patients with chronic active hepatitis type B. Clin Exp Immunol 1986 ; 67: 497–506.
7. 7 Tsai SL, Chen PJ, Lai MY, Yang PM, Sung JL, Huang JH, Hwang LH, et al. Acute exacerbations of chronic type B hepatitis are accompanied by increased T cell responses to hepatitis B core and e antigens. J Clin Invest 1992 ; 89: 87–96. MEDLINE
8. 8 Magnius LO, Espmark JA. New specificities in Australia antigen positive sera distinct from the Le Bouvier determinants. J Immunol 1972 ; 109: 1017–1025. MEDLINE
9. 9 Carman WF, Hadziyannis S, McGarvey MJ, Jacyna MR, Karayiannis P, Makris A, Thomas HC. Mutation preventing formation of hepatitis B e antigen in patients with chronic hepatitis B infection. Lancet 1989 ; II: 588–590.
10. 10 Omata M, Ehata T, Yokosuka O, Hosoda K, Ohto M. Mutations in the precore region of hepatitis B virus DNA in patients with fulminant and severe hepatitis. N Engl J Med 1991 ; 324: 1699–704. MEDLINE
11. 11 Akahane Y, Yamanaka T, Suzuki H, Sugai Y, Tsuda F, Yotsumoto S, Omi S, et al. Chronic active hepatitis with hepatitis B virus DNA and antibody against e antigen in the serum. Gastroenterology 1990 ; 99: 1113–1119. MEDLINE
12. 12 Brunetto MR, Giarin MM, Oliveri F, Chiaberge E, Baldi M, Alfarano A, Serra A, et al. Wild‐type and e antigen‐minus hepatitis B viruses and course of chronic hepatitis. Proc Natl Acad Sci U S A 1991 ; 88: 4186–4190. MEDLINE
13. 13 Hamasaki K, Nakata K, Nagayama Y, Ohtsuru A, Daikoku M, Taniguchi K, Tsutsumi T, et al. Changes in the prevalence of HBeAg‐negative mutant hepatitis B virus during the course of chronic hepatitis B. Hepatology 1994 ; 20: 8–14. MEDLINE
14. 14 Okamoto H, Yotsumoto S, Akahane Y, Yamanaka T, Miyazaki Y, Sugai Y, Tsuda F, et al. Hepatitis B viruses with precore region defects prevail in persistently infected hosts along with seroconversion to the antibody against e antigen. J Virol 1990 ; 64: 1298–1303. MEDLINE
15. 15 Guidotti LG, Ishikawa T, Hobbs MV, Matzke B, Schreiber R, Chisari FV. Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes. Immunity 1996 ; 4: 23–26.
16. 16 Maruyama T, McLachlan A, Iino S, Koike K, Kurokawa K, Milich DR. The serology of chronic hepatitis B infection revisited. J Clin Invest 1993 ; 91: 2586–2595. MEDLINE
17. 17 Maruyama T, Thornton GB, Iino S, Kurokawa K, Milich DR. Use of anti‐peptide antibodies for the design of antigen‐specific immune complex assays. J Immunol Methods 1992 ; 155: 65–75. MEDLINE
18. 18 Lieberman HM, LaBrecque DR, Kew MC, Hadziyannis SJ, Shafritz DA. Detection of hepatitis B virus DNA directly in human serum by a simplified molecular hybridization test: comparison to HBeAg/anti‐HBe status in HBsAg carriers. Hepatology 1983 ; 3: 285–291. MEDLINE
19. 19 Santantonio T, Jung M‐C, Miska S, Pastore G, Pape GR, Will H. Prevalence and type of pre‐C HBV mutants in anti‐HBe positive carriers with chronic liver disease in a highly endemic area. Virology 1991 ; 183: 840–844. MEDLINE
20. 20 Carman WF, Ferrao M, Lok ASF, Ma OCK, Lai CL, Thomas HC. Precore sequence variation in Chinese isolates of hepatitis B virus. J Infect Dis 1992 ; 165: 127–133. MEDLINE
21. 21 Akarca US, Greene S, Lok ASF. Detection of precore hepatitis B virus mutants in asymptomatic HBsAg‐positive family members. Hepatology 1994 ; 19: 1366–1370. MEDLINE
22. 22 Xu J, Brown D, Harrison T, Lin Y, Dusheiko G. Absence of hepatitis B virus precore mutants in patients with chronic hepatitis B responding to interferon‐α. Hepatology 1992 ; 15: 1002–1006. MEDLINE
23. 23 Loriot MA, Marcellin P, Talbodec N, Guigonis V, Gigou M, Boyer N, Bezeaud A, et al. Low frequency of precore hepatitis B virus mutants in anti–hepatitis B e–positive reactivation after loss of hepatitis B e antigen in patients with chronic hepatitis B. Hepatology 1995 ; 21: 627–631. MEDLINE
24. 24 Maruyama T, Iino S, Koiike K, Yasuda K, Milich DR. Serology of acute exacerbation in chronic hepatitis B virus infection. Gastroenterology 1993 ; 105: 1141–1151. MEDLINE
25. 25 Rehermann B, Pasquinelli C, Mosier SM, Chisari FV. Hepatitis B virus (HBV) sequence variation in cytotoxic T lymphocyte epitopes is not common in patients with chronic HBV infection. J Clin Invest 1995, 96: 1527–1534.
26. 26 Ferrari C, Penna A, Giuberti T, Tong MJ, Ribera E, Fiaccadori F, Chisari FV. Intrahepatic, nucleocapsid antigen‐specific T cells in chronic active hepatitis B. J Immunol 1987 ; 139: 2050–2058. MEDLINE
27. 27 Milich DR, Jones JE, Hughes JL, Maruyama T, Price J, Melhado I, Jirik J. Extrathymic expression of the intracellular hepatitis B core antigen results in T cell tolerance in transgenic mice. J Immunol 1994, 152: 455–460.
28. 28 Chu C‐M, Liaw Y‐F. Intrahepatic distribution of hepatitis B surface and core antigens in chronic hepatitis B virus infection. Gastroenterology 1987 ; 92: 796–802. MEDLINE
29. 29 Yoo JY, Howard R, Waggoner JG, Hoofnagle JH. Peroxidase‐anti‐peroxidase detection of hepatitis B surface and core antigen in liver biopsy specimens from patients with chronic type B hepatitis. J Med Virol 1987 ; 23: 273–281. MEDLINE
30. 30 Okamoto H, Tsuda F, Akahane Y, Sugai Y, Yoshiba M, Moriyama K, Tanaka T, et al. Hepatitis B virus with mutations in the core promoter for an e antigen–negative phenotype in carriers with antibody to e antigen. J Virol 1994 ; 68: 8102–8110. MEDLINE
31. 31 Michalak TI, Pasquinelli C, Guilhot S, Chisari FV. Hepatitis B virus persistence after recovery from acute viral hepatitis. J Clin Invest 1994 ; 93: 230–239. MEDLINE
32. 32 Rehermann B, Fowler P, Sidney J, Person J, Redeker A, Brown M, Moss B, et al. The cytotoxic T lymphocyte response to multiple hepatitis B virus polymerase epitopes during and after acute viral hepatitis. J Exp Med 1995 ; 181: 1047–1058. MEDLINE